Package 17856-8083-1

{"route": ["ORAL"], "spl_id": "4032ed04-0061-c22c-e063-6394a90a2ba1", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["4032ce02-e2b3-d426-e063-6294a90ab6c9"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8083-1)  / 5 mL in 1 CUP, UNIT-DOSE", "package_ndc": "17856-8083-1", "marketing_start_date": "20251001"}], "brand_name": "Acyclovir", "product_id": "17856-8083_4032ed04-0061-c22c-e063-6394a90a2ba1", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "17856-8083", "generic_name": "Acyclovir", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA074738", "marketing_category": "ANDA", "marketing_start_date": "20020903", "listing_expiration_date": "20261231"}